Gastroesophageal reflux disease medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(One intermediate revision by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
The mainstay treatment of GERD is lifestyle modifications which include [[weight loss]], elevating head of the bed and no eating before going sleep. The pharmacologic medical therapy is recommended among patients with persistent GERD despite following the lifestyle modifications. [[Antacids]], [[H2 antagonist|histamine receptor antagonists]], [[proton pump inhibitors]], and [[Prokinetic|prokinetics medications]] are used in treatment of GERD.


==Medical Therapy==
==Medical Therapy==
Line 27: Line 28:
* The medical therapy is indicated for the patients who have persistent GERD regardless the lifystyle and food modifications.<ref name="pmid17229239">{{cite journal |author=Tran T, Lowry A, El-Serag H |title=Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease drugs |journal=Aliment Pharmacol Ther |volume=25 |issue=2 |pages=143-53 |year=2007 |id=PMID 17229239 | doi=10.1111/j.1365-2036.2006.03135.x}}</ref><ref>Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn. ''Am J Ther'' 1995;2:546-552. PMID 11854825.</ref>
* The medical therapy is indicated for the patients who have persistent GERD regardless the lifystyle and food modifications.<ref name="pmid17229239">{{cite journal |author=Tran T, Lowry A, El-Serag H |title=Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease drugs |journal=Aliment Pharmacol Ther |volume=25 |issue=2 |pages=143-53 |year=2007 |id=PMID 17229239 | doi=10.1111/j.1365-2036.2006.03135.x}}</ref><ref>Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn. ''Am J Ther'' 1995;2:546-552. PMID 11854825.</ref>
* The following medical therapies are strongly recommended by the American College of Gastroenterology:  
* The following medical therapies are strongly recommended by the American College of Gastroenterology:  
** '''Antacids''':
** '''[[Antacids]]''':
*** Preferred regimen (1): [[Aluminum hydroxide]] 640 mg 5 to 6 times daily PO after meals and at bed time.  
*** Preferred regimen (1): [[Aluminum hydroxide]] 640 mg 5 to 6 times daily PO after meals and at bed time.  
*** Preferred regimen (2): [[Calcium carbonate]] One gram PO.  
*** Preferred regimen (2): [[Calcium carbonate]] One gram PO.  
Line 34: Line 35:
*** Preferred regimen (2): [[Cimetidine]] 400 mg q6h or 800 mg q12 PO for 12 weeks  
*** Preferred regimen (2): [[Cimetidine]] 400 mg q6h or 800 mg q12 PO for 12 weeks  
*** Preferred regimen (3): [[Famotidine]] 20 mg q12 PO for 6 weeks  
*** Preferred regimen (3): [[Famotidine]] 20 mg q12 PO for 6 weeks  
** '''Proton pump inhibitors:'''
** '''[[Proton pump inhibitors]]:'''
*** Preferred regimen (1): [[Omeprazole]] 20 mg q24 PO for up to 4 weeks
*** Preferred regimen (1): [[Omeprazole]] 20 mg q24 PO for up to 4 weeks
*** Preferred regimen (2): [[Esomeprazole]] 20 mg or 40 mg q24 IV  
*** Preferred regimen (2): [[Esomeprazole]] 20 mg or 40 mg q24 IV  
** '''Prokinetic medications:'''
** '''[[Prokinetic|Prokinetic medications]]:'''
*** Preferred regimen (1): [[Metoclopramide]] 10 mg q24 PO for 4 to 12 weeks
*** Preferred regimen (1): [[Metoclopramide]] 10 mg q24 PO for 4 to 12 weeks


Line 47: Line 48:


[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Primary care]]

Latest revision as of 21:50, 29 July 2020

Gastroesophageal reflux disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastroesophageal Reflux Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastroesophageal reflux disease medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastroesophageal reflux disease medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastroesophageal reflux disease medical therapy

CDC on Gastroesophageal reflux disease medical therapy

Gastroesophageal reflux disease medical therapy in the news

Blogs on Gastroesophageal reflux disease medical therapy

Directions to Hospitals Treating Gastroesophageal reflux disease

Risk calculators and risk factors for Gastroesophageal reflux disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The mainstay treatment of GERD is lifestyle modifications which include weight loss, elevating head of the bed and no eating before going sleep. The pharmacologic medical therapy is recommended among patients with persistent GERD despite following the lifestyle modifications. Antacids, histamine receptor antagonists, proton pump inhibitors, and prokinetics medications are used in treatment of GERD.

Medical Therapy

Lifestyle Modifications

  • The following measures are recommended as the first line to treat GERD:[1][2][3][4]
    • Weight loss
    • Elevating head of the bed
    • No eating two hours before going sleep
  • Avoidance of the following foods and lifestyles is recommended in treatment of GERD:

Medical therapy

  • The medical therapy is indicated for the patients who have persistent GERD regardless the lifystyle and food modifications.[5][6]
  • The following medical therapies are strongly recommended by the American College of Gastroenterology:

References

  1. Piesman M, Hwang I, Maydonovitch C, Wong RK (2007). "Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter?". Am. J. Gastroenterol. 102 (10): 2128–34. doi:10.1111/j.1572-0241.2007.01348.x. PMID 17573791.
  2. Kaltenbach T, Crockett S, Gerson LB (2006). "Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach". Arch. Intern. Med. 166 (9): 965–71. doi:10.1001/archinte.166.9.965. PMID 16682569.
  3. Ness-Jensen E, Hveem K, El-Serag H, Lagergren J (2016). "Lifestyle Intervention in Gastroesophageal Reflux Disease". Clin Gastroenterol Hepatol. 14 (2): 175-82.e1-3. doi:10.1016/j.cgh.2015.04.176. PMC 4636482. PMID 25956834.
  4. Khoury RM, Camacho-Lobato L, Katz PO, Mohiuddin MA, Castell DO. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 1999;94:2069-73. PMID 10445529.
  5. Tran T, Lowry A, El-Serag H (2007). "Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease drugs". Aliment Pharmacol Ther. 25 (2): 143–53. doi:10.1111/j.1365-2036.2006.03135.x. PMID 17229239.
  6. Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn. Am J Ther 1995;2:546-552. PMID 11854825.

Template:WH Template:WS